Disclosures
Dr Giannitsis reports grants and personal fees from Roche Diagnostics and Daiichi Sankyo; personal fees from Bayer Vital, Boehringer Ingelheim, AstraZeneca, BRAHMS Deutschland, Novo Nordisk, Idorsia, Radiometer, and Mitsubishi Chemicals, outside the submitted work. Dr Budaj reports personal fees and nonfinancial support from AstraZeneca, during the conduct of the study; personal fees and nonfinancial support from Bristol Myers Squibb and Sanofi Aventis; personal fees from Eisai, Novartis, GlaxoSmithKline, and Amgen; personal fees and nonfinancial support from Bayer, outside the submitted work. Dr Katus reports personal fees from Bayer, AstraZeneca, and Daiichi, outside the submitted work. Dr Storey reports research grants and personal fees from AstraZeneca, Cytosorbents, GlyCardial Diagnostics, and Thromboserin; personal fees from Alnylam, Bayer, Bristol Myers Squibb/Pfizer, Chiesi, CSL Behring, HengRui, Idorsia, Intas Pharmaceuticals, Medscape, Novartis, PhaseBio, Portola, and Sanofi Aventis. Dr Cornel reports membership of advisory boards with Amgen and AstraZeneca. Dr Siegbahn reports institutional research grants from AstraZeneca, Boehringer Ingelheim, Bristol‐Myers Squibb/Pfizer, GlaxoSmithKline, and Roche Diagnostics, outside the submitted work. Dr Hjort, Dr Eggers, T. Ghukasyan Lakic, J. Lindbäck, Dr Becker, Dr Wallentin, and Dr Lindahl have nothing to declare.